(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide

C125H131N19O17S2 — CID 159072172

IUPAC(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide
SMILESC[C@@H]1CC(=O)Nc2ccc(OCC3CC3)cc2O1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc(C(=O)NC4CC4)cc3)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc(NS(C)(=O)=O)cc3)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)CC(=O)N4)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)CC(=O)N4C)c2N1.C[C@@H]1CC(=O)Nc2cccc(/C=C/c3ccccc3S(N)(=O)=O)c2N1.Cc1cc2c(cnn2C)cc1-c1cccc2c1O[C@H](C)CC(=O)N2
InChIInChI=1S/C20H21N3O2.2C19H19N3O2.C18H19N3O3S.C18H17N3O2.C17H19N3O3S.C14H17NO3/c1-12-11-18(24)23-17-4-2-3-16(19(17)21-12)13-5-7-14(8-6-13)20(25)22-15-9-10-15;1-11-7-17-13(10-20-22(17)3)9-15(11)14-5-4-6-16-19(14)24-12(2)8-18(23)21-16;1-11-8-17(23)21-15-5-3-4-14(19(15)20-11)12-6-7-16-13(9-12)10-18(24)22(16)2;1-12-11-17(22)21-15-7-4-6-14(18(15)20-12)10-9-13-5-2-3-8-16(13)25(19,23)24;1-10-7-16(22)21-15-4-2-3-13(18(15)19-10)11-5-6-14-12(8-11)9-17(23)20-14;1-11-10-16(21)19-15-5-3-4-14(17(15)18-11)12-6-8-13(9-7-12)20-24(2,22)23;1-9-6-14(16)15-12-5-4-11(7-13(12)18-9)17-8-10-2-3-10/h2-8,12,15,21H,9-11H2,1H3,(H,22,25)(H,23,24);4-7,9-10,12H,8H2,1-3H3,(H,21,23);3-7,9,11,20H,8,10H2,1-2H3,(H,21,23);2-10,12,20H,11H2,1H3,(H,21,22)(H2,19,23,24);2-6,8,10,19H,7,9H2,1H3,(H,20,23)(H,21,22);3-9,11,18,20H,10H2,1-2H3,(H,19,21);4-5,7,9-10H,2-3,6,8H2,1H3,(H,15,16)/b;;;10-9+;;;/t2*12-;11-;12-;10-;11-;9-/m1111111/s1
InChIKeyJZUGYRMMARAIGA-HQIUOSQQSA-N
MW2235.67 g/mol
LogP21.15
Rot. Bonds15

About (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide

(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide (PubChem CID 159072172) has the molecular formula C125H131N19O17S2 and a molecular weight of 2235.67 g/mol. Its IUPAC name is (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide.

Molecular Properties

Compound Name(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide
PubChem CID159072172
Molecular FormulaC125H131N19O17S2
Molecular Weight2235.67 g/mol
Exact Mass2233.94
IUPAC Name(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide
SMILESC[C@@H]1CC(=O)Nc2ccc(OCC3CC3)cc2O1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc(C(=O)NC4CC4)cc3)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc(NS(C)(=O)=O)cc3)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)CC(=O)N4)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)CC(=O)N4C)c2N1.C[C@@H]1CC(=O)Nc2cccc(/C=C/c3ccccc3S(N)(=O)=O)c2N1.Cc1cc2c(cnn2C)cc1-c1cccc2c1O[C@H](C)CC(=O)N2
InChIInChI=1S/C20H21N3O2.2C19H19N3O2.C18H19N3O3S.C18H17N3O2.C17H19N3O3S.C14H17NO3/c1-12-11-18(24)23-17-4-2-3-16(19(17)21-12)13-5-7-14(8-6-13)20(25)22-15-9-10-15;1-11-7-17-13(10-20-22(17)3)9-15(11)14-5-4-6-16-19(14)24-12(2)8-18(23)21-16;1-11-8-17(23)21-15-5-3-4-14(19(15)20-11)12-6-7-16-13(9-12)10-18(24)22(16)2;1-12-11-17(22)21-15-7-4-6-14(18(15)20-12)10-9-13-5-2-3-8-16(13)25(19,23)24;1-10-7-16(22)21-15-4-2-3-13(18(15)19-10)11-5-6-14-12(8-11)9-17(23)20-14;1-11-10-16(21)19-15-5-3-4-14(17(15)18-11)12-6-8-13(9-7-12)20-24(2,22)23;1-9-6-14(16)15-12-5-4-11(7-13(12)18-9)17-8-10-2-3-10/h2-8,12,15,21H,9-11H2,1H3,(H,22,25)(H,23,24);4-7,9-10,12H,8H2,1-3H3,(H,21,23);3-7,9,11,20H,8,10H2,1-2H3,(H,21,23);2-10,12,20H,11H2,1H3,(H,21,22)(H2,19,23,24);2-6,8,10,19H,7,9H2,1H3,(H,20,23)(H,21,22);3-9,11,18,20H,10H2,1-2H3,(H,19,21);4-5,7,9-10H,2-3,6,8H2,1H3,(H,15,16)/b;;;10-9+;;;/t2*12-;11-;12-;10-;11-;9-/m1111111/s1
InChIKeyJZUGYRMMARAIGA-HQIUOSQQSA-N
XLogP21.15
TPSA494.20 Ų
H-Bond Donors16
H-Bond Acceptors24
Rotatable Bonds15
Heavy Atoms163
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002235.67
LogP ≤ 521.15
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'stilbene', 'substructure': 'N/A'}

Analyze (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide?
The IUPAC name of (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide (CID 159072172) is (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide.
What is the SMILES notation for (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide?
The canonical SMILES for (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide is C[C@@H]1CC(=O)Nc2ccc(OCC3CC3)cc2O1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc(C(=O)NC4CC4)cc3)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc(NS(C)(=O)=O)cc3)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)CC(=O)N4)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)CC(=O)N4C)c2N1.C[C@@H]1CC(=O)Nc2cccc(/C=C/c3ccccc3S(N)(=O)=O)c2N1.Cc1cc2c(cnn2C)cc1-c1cccc2c1O[C@H](C)CC(=O)N2.
What is the InChIKey of (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide?
The InChIKey is JZUGYRMMARAIGA-HQIUOSQQSA-N. The full InChI is InChI=1S/C20H21N3O2.2C19H19N3O2.C18H19N3O3S.C18H17N3O2.C17H19N3O3S.C14H17NO3/c1-12-11-18(24)23-17-4-2-3-16(19(17)21-12)13-5-7-14(8-6-13)20(25)22-15-9-10-15;1-11-7-17-13(10-20-22(17)3)9-15(11)14-5-4-6-16-19(14)24-12(2)8-18(23)21-16;1-11-8-17(23)21-15-5-3-4-14(19(15)20-11)12-6-7-16-13(9-12)10-18(24)22(16)2;1-12-11-17(22)21-15-7-4-6-14(18(15)20-12)10-9-13-5-2-3-8-16(13)25(19,23)24;1-10-7-16(22)21-15-4-2-3-13(18(15)19-10)11-5-6-14-12(8-11)9-17(23)20-14;1-11-10-16(21)19-15-5-3-4-14(17(15)18-11)12-6-8-13(9-7-12)20-24(2,22)23;1-9-6-14(16)15-12-5-4-11(7-13(12)18-9)17-8-10-2-3-10/h2-8,12,15,21H,9-11H2,1H3,(H,22,25)(H,23,24);4-7,9-10,12H,8H2,1-3H3,(H,21,23);3-7,9,11,20H,8,10H2,1-2H3,(H,21,23);2-10,12,20H,11H2,1H3,(H,21,22)(H2,19,23,24);2-6,8,10,19H,7,9H2,1H3,(H,20,23)(H,21,22);3-9,11,18,20H,10H2,1-2H3,(H,19,21);4-5,7,9-10H,2-3,6,8H2,1H3,(H,15,16)/b;;;10-9+;;;/t2*12-;11-;12-;10-;11-;9-/m1111111/s1.
What are the key properties of (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide?
(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide has a molecular weight of 2235.67 g/mol, XLogP of 21.15, 15 rotatable bonds, 16 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;N-cyclopropyl-4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]benzamide;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(2-oxo-1,3-dihydroindol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;2-[(E)-2-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]ethenyl]benzenesulfonamide;N-[4-[(4R)-4-methyl-2-oxo-1,3,4,5-tetrahydro-1,5-benzodiazepin-6-yl]phenyl]methanesulfonamide is sourced from PubChem (CID 159072172), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).